07:00 , May 5, 2014 |  BC Week In Review  |  Company News

Tiziana Life Sciences deal

Tiziana Pharma Ltd. completed its reverse merger with Alexander David Investments plc (ADI) to form newco Tiziana Life Sciences plc in a deal that values Tiziana at £7.5 million ($12.6 million) (see BioCentury, April 14)....
07:00 , Apr 14, 2014 |  BC Week In Review  |  Company News

Alexander David Investments plc, Tiziana Pharma Ltd. deal

Alexander David Investments (ADI) will reverse-merge with Tiziana in a deal that values Tiziana at £7.5 million ($12.5 million). ADI will issue 62.5 million shares at 12p per share. In connection with the reverse merger,...